Clinical Trials
4 trialsNCT00993512 2019-04-29
Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer
PCI Biotech AS
Phase 1 Completed
NCT01060904 2014-12-18
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
Seagen Inc.
Phase 1 Completed
NCT01872923 2014-06-16
Dose Escalating Study for Amphinex-based PCI of Bleomycin.
PCI Biotech AS
Phase 1 Completed
NCT00027521 2012-09-19
Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer
Ichor Medical Systems Incorporated
Phase 1 Withdrawn